Evidence map›Paper›PMID 35365212›Full record

ArticleJournal of pharmaceutical policy and practice2022

Redistribution of critical drugs in shortage during the first wave of COVID-19 in France: from operating theaters to intensive care units.

Claire Chapuis, Rémy Collomp, Laura Albaladejo, Hugo Terrisse, Stéphane Honoré, Jean-Luc Bosson, Pierrick Bedouch, Pierre Albaladejo

Open access · goldAbstract read
In one paragraph

Article in Journal of pharmaceutical policy and practice, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
4.3field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Review
  3. Medicine shortages: impact behind numbers.Journal of pharmaceutical policy and practice · 2023
    Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Claire ChapuisPôle Pharmacie, Pôle Anesthésie-Réanimation, CHU Grenoble Alpes, CS10217, 380143, Grenoble cedex 9, France. cchapuis1@chu-grenoble.fr.ORCID http://orcid.org/0000-0002-0076-6335
Rémy CollompPôle Pharmacie Stérilisation, CHU De Nice, Société Française de Pharmacie Clinique (SFPC), Nice, France.
Laura AlbaladejoEquipe Themas, Timc-Imag Umr5525, Université Grenoble Alpes, Grenoble, France.
Hugo TerrisseEquipe Themas, Timc-Imag Umr5525, Université Grenoble Alpes, Grenoble, France.
Stéphane HonoréPôle Pharmacie, Hôpital De La Timone, Société Française de Pharmacie Clinique (SFPC), Marseille, France.
Jean-Luc BossonEquipe Themas, Timc-Imag Umr5525, Université Grenoble Alpes, Grenoble, France.
Pierrick BedouchEquipe Themas, Timc-Imag Umr5525, Université Grenoble Alpes, Grenoble, France.
Pierre AlbaladejoEquipe Themas, Timc-Imag Umr5525, Université Grenoble Alpes, Grenoble, France.
Centre Hospitalier Universitaire de Grenoble · FRUniversité Grenoble Alpes · FRHôpital de la Timone · FRSociété Française de Cardiologie · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundTension in the supply of highly consumed drugs for patients with COVID-19 (propofol, midazolam, curares) led the French government to set up a centralized supply of hospitals with distribution based on the number of resuscitation beds in March 2020. The French Societies of Clinical Pharmacy and of Anesthesia and Critical Care aimed to evaluate the changes in total needs and the distribution between anesthesia and critical care activities (CCU), to prepare resumed surgical activity.

methodsNational declarative survey among pharmacists, via an online form (SurveyMonkey®), was conducted in April and May 2020. The analysis focused on quantities dispensed during the whole year 2019, and March and April of year 2019 and 2020 for the drugs subject to quota, and on their distribution in CCU and operating theaters.

resultsFor the 358 establishments (47% public, 53% private), dispensations in CCU in March 2020 compared to March 2019 increased, respectively: propofol (+81%), midazolam (+125%), cisatracurium (+311%), atracurium (+138%), rocuronium (+119%); and decreased for anaesthesia: propofol (-27%), midazolam (-10%), cisatracurium (-19%), atracurium (-27%), rocuronium (+16%).

conclusionsVariation of dispensations between CCU and others was directly related to the increase of COVID patients in CCU and the decrease in surgical activity. Each establishment could receive up to five or six different presentations and concentrations, leading to a major risk of medication error. This collaborative national survey provided accurate data on the drugs' usual consumption. This work emphasized the need for a strong collaboration between pharmacists and anesthesiologists and intensive care physicians. It was further used by the Health Ministry to adjust the drug distribution.

Indexed as

AnestheticsCritical care(MeSH): anesthesiaShortageSurvey

Identifiers

PMID35365212
PMCPMC8972643
OpenAlexW4220954844

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.